FDA Approves Risankizumab-rzaa for PsA Michele B. Kaufman, PharmD, BCGP | April 20, 2022Two recent trials demonstrated the safety and efficacy of risankizumab-rzaa for the treatment of adults with active psoriatic arthritis.